Toll-like Receptor Signaling–deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing

Cancer immunotherapy aims to activate the immune system. Some immunotherapeutic agents can be loaded in carrier cells for delivering to the tumors. However, a challenge with cell-based therapies is the selection of the appropriate cells to produce effective clinical outcomes. We hypothesize that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales-Molina, Alvaro, Rodriguez-Milla, Miguel Ángel, Gambera, Stefano, Cejalvo, Teresa, de Andrés, Belén, Gaspar, María-Luisa, García-Castro, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976589/
https://www.ncbi.nlm.nih.gov/pubmed/36875156
http://dx.doi.org/10.1158/2767-9764.CRC-22-0365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976589/
https://www.ncbi.nlm.nih.gov/pubmed/36875156
http://dx.doi.org/10.1158/2767-9764.CRC-22-0365

Ejemplares similares